A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

NCT00431236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

810

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG: Oral Casopitant (GW679769)
DRUG: IV Casopitant (GW679769)
DRUG: IV ondansetron hydrochloride
DRUG: Oral dexamethasone

Sponsor

GlaxoSmithKline